Company intelligence / Profile preview

Ryght

Anaheim, California, United Statesryght.ai ↗

Ownership: Private
Development stage: Other

Overview

Ryght has rapidly deployed its generative/agentic AI-powered SaaS platform to automate manual processes in clinical trials. The system creates "digital twins" of every global trial site to match protocols with optimal sites, accelerating site selection from months to weeks. It has signed six figure deals with pharmaceutical companies and partnered with major CROs like QPS Holdings. Academic partners include the Medical College of Wisconsin. The network aims to reduce costs and timelines while improving enrollment success rates. No direct drug development or clinical results as the company provides enabling technology.

Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

QPS Holdings (global CRO partner adding >750 sites in 17 countries)Medical College of Wisconsin (academic partner)Technology/cloud service providers

Beyond the preview

Go deeper on Ryght.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ryght.

Explore the full profile